Slimming Products - Mexico

Date: June 22, 2010
Pages: 45
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S79535D2138EN
Leaflet:

Download PDF Leaflet

In 2009, COFEPRIS, the regulatory agency in Mexico, alerted Mexicans about slimming products containing toxic ingredients such as thevetia and chromium picolinate, linked to cardiovascular, neurological and dermatological damage. Most of these products are locally manufactured at clandestine locations, such as car garages or small warehouses. COFEPRIS also made a strong statement against most of the companies selling weight loss products, saying that they are putting at risk the health of...

Euromonitor International's Slimming Products Products in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Meal Replacement Slimming, Other Slimming Products, Slimming Teas, Weight Loss Supplements

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health industry;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Dynamic Growth in Consumer Health Comes To A Halt in 2009
H1n1 Influenza Epidemic Transforms Perception of Self-medication
Emerging Strength of Generic Products Shapes the Regulatory Environment
Retailing Becomes An Important Battle Ground for Pharmaceutical Companies
Retail Value To Flatten Over the Forecast Period
Key Trends and Developments
Mexicans Move To Low-priced Products
Generics and Private Label Increase Sales
New Legislation To Affect Imports and the Drug Registry
Self-care Education Still Lagging
Chronic Diseases To Drive Growth
the Creativity of OTC Drug Advertising in Mexico
Retailing Becomes A Major Scenario for Competitive Wars
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
  Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
  Summary 2 Research Sources
Bayer De México SA De Cv
Strategic Direction
Key Facts
  Summary 3 Bayer de México SA de CV: Key Facts
  Summary 4 Bayer de México SA de CV: Operational Indicators
Company Background
Production
  Summary 5 Bayer de México SA de CV: Production Statistics 2009
Competitive Positioning
  Summary 6 Bayer de México SA de CV: Competitive Position 2009
Boehringer Ingelheim Promeco SA De Cv
Strategic Direction
Key Facts
  Summary 7 Boehringer Ingelheim Promeco SA de CV: Key Facts
  Summary 8 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
  Summary 9 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2009
Competitive Positioning
  Summary 10 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2009
Farmacias Similares SA De Cv
Strategic Direction
Key Facts
  Summary 11 Farmacias Similares SA de CV: Key Facts
  Summary 12 Farmacias Similares SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 13 Farmacias Similares SA de CV: Competitive Position 2009
Genomma Lab Internacional Sab De Cv
Strategic Direction
Key Facts
  Summary 14 Genomma Lab Internacional SAB de CV: Key Facts
  Summary 15 Genomma Lab Internacional SAB de CV: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 16 Genomma Lab Internacional SAB de CV: Competitive Position 2009
GlaxoSmithKline México SA De Cv
Strategic Direction
Key Facts
  Summary 17 GlaxoSmithKline México SA de CV: Key Facts
  Summary 18 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
  Summary 19 GlaxoSmithKline México SA de CV: Production Statistics 2009
Competitive Positioning
Herbalife Internacional De México SA De Cv
Strategic Direction
Key Facts
  Summary 21 Herbalife Internacional de México SA de CV: Key Facts
  Summary 22 Herbalife Internacional de México SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 23 Herbalife Internacional de México SA de CV: Competitive Position 2009
Merck-méxico SA
Strategic Direction
Key Facts
  Summary 24 Merck-México SA: Key Facts
  Summary 25 Merck-México SA: Operational Indicators
Company Background
Production
  Summary 26 Merck-México SA: Production Statistics 2009
Competitive Positioning
  Summary 27 Merck-México SA: Competitive Position 2009
Pfizer SA De Cv
Strategic Direction
Key Facts
  Summary 28 Pfizer SA de CV: Key Facts
  Summary 29 Pfizer SA de CV: Operational Indicators
Company Background
Production
  Summary 30 Pfizer SA de CV: Production Statistics 2009
Competitive Positioning
  Summary 31 Pfizer SA de CV: Competitive Position 2009
  Summary 32 Wyeth SA de CV: Competitive Position 2009
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 11 Sales of Slimming Products by Subsector: Value 2004-2009
  Table 12 Sales of Slimming Products by Subsector: % Value Growth 2004-2009
  Table 13 Slimming Products Company Shares 2005-2009
  Table 14 Slimming Products Brand Shares 2006-2009
  Table 15 Forecast Sales of Slimming Products by Subsector: Value 2009-2014
  Table 16 Forecast Sales of Slimming Products by Subsector: % Value Growth 2009-2014
Skip to top


Slimming Products - France US$ 990.00 Apr, 2010 · 54 pages
Slimming Products - Germany US$ 990.00 Apr, 2010 · 43 pages
Slimming Products - Greece US$ 990.00 Mar, 2010 · 36 pages
Slimming Products - Guatemala US$ 990.00 May, 2010 · 22 pages
Slimming Products - India US$ 990.00 Mar, 2010 · 51 pages

Ask Your Question

Slimming Products - Mexico
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: